Cinzia Rinaldo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Validation of a Cellular Imaging-Based Method as a Potential Biomarker for SPG4 Hereditary Spastic Paraplegia.

Validation of a Cellular Imaging-Based Method as a Potential Biomarker for SPG4 Hereditary Spastic Paraplegia.

Journal: Annals of clinical and translational neurology

Published: March 27, 2026

Significant differences in phenotype and age of onset in an SPG4 family caused by whole SPAST deletion combined with a hemizygous S44L modifier.

Significant differences in phenotype and age of onset in an SPG4 family caused by whole SPAST deletion combined with a hemizygous S44L modifier.

Journal: Neurogenetics

Published: March 16, 2026

Mutation type-specific transcriptomic signatures and readthrough therapy rescue in SMC1A-related developmental and epileptic encephalopathy.

Mutation type-specific transcriptomic signatures and readthrough therapy rescue in SMC1A-related developmental and epileptic encephalopathy.

Journal: Epilepsia

Published: October 30, 2025

Targeting the MDM2-MDM4 interaction interface reveals an otherwise therapeutically active wild-type p53 in colorectal cancer.

Targeting the MDM2-MDM4 interaction interface reveals an otherwise therapeutically active wild-type p53 in colorectal cancer.

Journal: Molecular oncology

Published: September 13, 2024

Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment.

Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment.

Journal: Cell death discovery

Published: September 02, 2024

Inactivation of HIPK2 attenuates KRASG12D activity and prevents pancreatic tumorigenesis.

Inactivation of HIPK2 attenuates KRASG12D activity and prevents pancreatic tumorigenesis.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 31, 2024

Cul-4 inhibition rescues spastin levels and reduces defects in hereditary spastic paraplegia models.

Cul-4 inhibition rescues spastin levels and reduces defects in hereditary spastic paraplegia models.

Journal: Brain : a journal of neurology

Published: August 12, 2023

HIPK2 in the physiology of nervous system and its implications in neurological disorders.

HIPK2 in the physiology of nervous system and its implications in neurological disorders.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: January 20, 2023

New cellular imaging-based method to distinguish the SPG4 subtype of hereditary spastic paraplegia.

New cellular imaging-based method to distinguish the SPG4 subtype of hereditary spastic paraplegia.

Journal: European journal of neurology

Published: December 23, 2022

HIPK2 Is Required for Midbody Remnant Removal Through Autophagy-Mediated Degradation.

HIPK2 Is Required for Midbody Remnant Removal Through Autophagy-Mediated Degradation.

Journal: Frontiers in cell and developmental biology

Published: June 12, 2020

Spastin recovery in hereditary spastic paraplegia by preventing neddylation-dependent degradation.

Spastin recovery in hereditary spastic paraplegia by preventing neddylation-dependent degradation.

Journal: Life science alliance

Published: May 28, 2020

An Alternative Splice Variant of HIPK2 with Intron Retention Contributes to Cytokinesis.

An Alternative Splice Variant of HIPK2 with Intron Retention Contributes to Cytokinesis.

Journal: Cells

Published: January 17, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026